Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

N Engl J Med. 2011 Dec 15;365(24):2334-5; author reply 2335. doi: 10.1056/NEJMc1112233.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anticoagulants / therapeutic use*
  • Atrial Fibrillation / drug therapy*
  • Female
  • Humans
  • Male
  • Morpholines / therapeutic use*
  • Thiophenes / therapeutic use*
  • Warfarin / therapeutic use*

Substances

  • Anticoagulants
  • Morpholines
  • Thiophenes
  • Warfarin